Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
Online access: Training course on reducing barriers to medicines in Africa
NewsMaking intellectual property issues easier to understand, to increase access to medicines – and you can apply now! An online...
Read more about Online access: Training course on reducing barriers to medicines in Africa
-
Tackling the hepatitis C epidemic in Malaysia
NewsWith new, revolutionary, drugs available, why isn’t everyone getting the cure? An estimated 454,000 people are living with hepatitis C...
Read more about Tackling the hepatitis C epidemic in Malaysia
-
An important step towards affordable TAF in Ukraine
NewsGilead adds TAF, a drug used in HIV and Hepatitis B treatment, to the Medicines Patent Pool for Ukraine. It...
Read more about An important step towards affordable TAF in Ukraine
-
IAS 2017: Closing ceremony exposes Gilead Sciences
NewsConference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science...
Read more about IAS 2017: Closing ceremony exposes Gilead Sciences
-
“We want dolutegravir for all, and we want it now.”
OpinionArticle first published on the Huffington Post here. We’re calling for a compulsory license on a ‘new’ HIV drug to...
Read more about “We want dolutegravir for all, and we want it now.”
-
A victory for ITPC-MENA : Bristol-Myers Squibb extends its voluntary license on atazanavir to Egypt
NewsDuring the 9th International AIDS Conference (23-26 July 2017), Bristol-Myers Squibb (BMS) and the Medicines Patent Pool (MPP) announced the...
-
HIV activists denounce ViiV for denying 3.5 million people access to optimal treatment
NewsToday, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment...
-
Intellectual Property Group opposes a resolution which would restrict access to medicines in Brazil
NewsOur partner in Brazil highlights the facts in a debate full of confusion. Last month, the Working Group on Intellectual...
-
Brazil: Open letter insists that pharmaceuticals’ interests must NOT be prioritized over public health
NewsThe Working Group on Intellectual Property responds to what it sees as ‘an attack on the rights of the Brazilian...
-
Victory: Gilead forced to withdraw Truvada® patent application in Argentina
NewsGilead prevented from obtaining an illegitimate monopoly at the expense of people’s health. Activists in Argentina, including our partner...
Read more about Victory: Gilead forced to withdraw Truvada® patent application in Argentina
